NGS-based RNA seq Market is estimated to increase at a growth rate of 19.5% CAGR over the forecast period from 2024 to 2030.
The global NGS-based RNA seq Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product & Service (Sample Preparation Products, RNA-sequencing Platforms and Consumables, RNA-sequencing Services, Data Analysis, Storage & Management), By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA-sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others).
An Introduction to NGS based RNA seq Market in 2024
The NGS-based RNA-seq Market in 2024 stands at the forefront of genomic research and precision medicine, witnessing unprecedented growth and technological advancements. Next-generation sequencing (NGS) technologies have revolutionized the study of RNA transcripts, enabling researchers to comprehensively analyze the transcriptome with unprecedented depth and accuracy. In addition to unraveling the complexities of gene expression and regulation, RNA-seq has emerged as a powerful tool for biomarker discovery, drug development, and personalized medicine. The market is characterized by the proliferation of innovative platforms, bioinformatics solutions, and analytical tools tailored to meet the diverse needs of researchers and clinicians across academia, pharmaceuticals, and clinical diagnostics. With ongoing efforts to improve sequencing efficiency, reduce costs, and enhance data interpretation, the NGS-based RNA-seq Market is poised to drive groundbreaking discoveries and transformative healthcare applications in the years to come.
NGS-based RNA seq Market Competitive Landscape
The global NGS-based RNA seq Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, NGS-based RNA seq Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the NGS-based RNA seq Industry include- Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Hamilton Company, Illumina,Inc, Oxford Nanopore Technologies, PerkinElmer Inc, Takara Bio Inc, Tecan Trading AG, Thermo Fisher Scientific Inc.
NGS based RNA seq Market Trend: Adoption of High-Throughput Sequencing Technologies
In the NGS based RNA seq market, a prominent trend is the widespread adoption of high-throughput sequencing technologies. Next-generation sequencing (NGS) platforms enable the rapid and cost-effective analysis of RNA molecules, allowing researchers to characterize gene expression profiles, identify alternative splicing events, and detect RNA modifications with unprecedented depth and resolution. The continued advancements in NGS instrumentation, sequencing chemistry, and bioinformatics tools have democratized RNA sequencing applications, making it accessible to researchers across diverse scientific disciplines. The adoption of NGS-based RNA sequencing fuels innovation in genomics research, transcriptomics, and biomarker discovery, driving growth in the NGS-based RNA seq market.
NGS based RNA seq Market Driver: Demand for Comprehensive Transcriptomic Profiling
The primary market driver for NGS-based RNA seq is the demand for comprehensive transcriptomic profiling. RNA sequencing offers insights into the complex landscape of gene expression patterns, regulatory mechanisms, and functional pathways underlying normal physiology and disease states. Researchers, clinicians, and pharmaceutical companies increasingly rely on RNA sequencing data to unravel molecular signatures associated with disease progression, drug response, and treatment resistance. The growing demand for comprehensive transcriptomic profiling drives the adoption of NGS-based RNA sequencing as a powerful tool for biomarker discovery, drug development, and precision medicine initiatives across therapeutic areas such as oncology, immunology, and neuroscience.
NGS based RNA seq Market Opportunity: Integration with Multi-Omics and Clinical Applications
An emerging opportunity in the NGS-based RNA seq market lies in the integration with multi-omics and clinical applications. Integrating RNA sequencing data with other omics datasets, such as DNA sequencing, epigenomics, and proteomics, offers a holistic view of biological systems and disease mechanisms, enabling deeper insights into molecular networks and therapeutic targets. Additionally, there is a growing interest in translating NGS-based RNA sequencing findings into clinical applications, including diagnostic assays, prognostic biomarkers, and companion diagnostics for precision medicine. Collaborative efforts between academic researchers, diagnostic companies, and healthcare providers can facilitate the development and validation of NGS-based RNA sequencing assays for clinical use, paving the way for personalized patient care and improved treatment outcomes in various disease settings.
NGS based RNA seq Market Share Analysis: Sequencing is the fastest growing market segment over the forecast period to 2030
Among the various technologies used in NGS-based RNA-seq, the segment experiencing significant growth is Sequencing By Synthesis (SBS). SBS technology utilizes fluorescently labeled nucleotides to sequence DNA or RNA fragments, enabling high-throughput and accurate sequencing of genetic material. In the context of RNA-seq, SBS offers several advantages, including high sensitivity, reproducibility, and the ability to detect gene expression levels with single-nucleotide resolution. The rapid growth of SBS in RNA-seq applications is driven by its widespread adoption in research and clinical settings for a wide range of applications, including expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, and variant calling. Additionally, advancements in SBS platforms and consumables, such as improved sequencing chemistry, enhanced throughput, and reduced sequencing costs, have further fueled its popularity. Research and academic institutions, hospitals and clinics, as well as pharmaceutical and biotechnology companies, are increasingly utilizing SBS-based RNA-seq to unravel the complexities of gene expression and regulation in health and disease. As NGS technologies continue to evolve and become more accessible, the adoption of SBS-based RNA-seq is expected to grow rapidly, driving innovation and discoveries in molecular biology and biomedical research.
NGS-based RNA seq Market Segmentation
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
NGS-based RNA seq Companies
Agilent Technologies Inc
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche Ltd
Hamilton Company
Illumina,Inc
Oxford Nanopore Technologies
PerkinElmer Inc
Takara Bio Inc
Tecan Trading AG
Thermo Fisher Scientific Inc
* List not Exhaustive
Reasons to Buy the NGS-based RNA seq Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the NGS-based RNA seq Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the NGS-based RNA seq Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 NGS-based RNA seq Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global NGS-based RNA seq Market Size Outlook, $ Million, 2021 to 2030
3.2 NGS-based RNA seq Market Outlook by Type, $ Million, 2021 to 2030
3.3 NGS-based RNA seq Market Outlook by Product, $ Million, 2021 to 2030
3.4 NGS-based RNA seq Market Outlook by Application, $ Million, 2021 to 2030
3.5 NGS-based RNA seq Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of NGS-based RNA seq Industry
4.2 Key Market Trends in NGS-based RNA seq Industry
4.3 Potential Opportunities in NGS-based RNA seq Industry
4.4 Key Challenges in NGS-based RNA seq Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global NGS-based RNA seq Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global NGS-based RNA seq Market Outlook by Segments
7.1 NGS-based RNA seq Market Outlook by Segments, $ Million, 2021- 2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
8 North America NGS-based RNA seq Market Analysis and Outlook To 2030
8.1 Introduction to North America NGS-based RNA seq Markets in 2024
8.2 North America NGS-based RNA seq Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America NGS-based RNA seq Market size Outlook by Segments, 2021-2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
9 Europe NGS-based RNA seq Market Analysis and Outlook To 2030
9.1 Introduction to Europe NGS-based RNA seq Markets in 2024
9.2 Europe NGS-based RNA seq Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe NGS-based RNA seq Market Size Outlook by Segments, 2021-2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
10 Asia Pacific NGS-based RNA seq Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific NGS-based RNA seq Markets in 2024
10.2 Asia Pacific NGS-based RNA seq Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific NGS-based RNA seq Market size Outlook by Segments, 2021-2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
11 South America NGS-based RNA seq Market Analysis and Outlook To 2030
11.1 Introduction to South America NGS-based RNA seq Markets in 2024
11.2 South America NGS-based RNA seq Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America NGS-based RNA seq Market size Outlook by Segments, 2021-2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
12 Middle East and Africa NGS-based RNA seq Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa NGS-based RNA seq Markets in 2024
12.2 Middle East and Africa NGS-based RNA seq Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa NGS-based RNA seq Market size Outlook by Segments, 2021-2030
By Product & Service
Sample Preparation Products
-Library Preparation and Target Enrichment
-Quality Control
-Manual Sample Preparation
-Microfluidic Sample Preparation
-Robotic Liquid Handling Sample Preparation
RNA-sequencing Platforms and Consumables
RNA-sequencing Services
Data Analysis, Storage & Management
By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By Application
Expression Profiling Analysis
Small RNA-sequencing
De Novo Transcriptome Assembly
Variant Calling and Transcriptome Epigenetics
By End-User
Research and Academia
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche Ltd
Hamilton Company
Illumina,Inc
Oxford Nanopore Technologies
PerkinElmer Inc
Takara Bio Inc
Tecan Trading AG
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
